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Abstract

Omega-3 long-chain polyunsaturated fatty acids (n-3 LCPUFA) have several health benefits. In particular, low
n-3 LCPUFA status is associated with cardiovascular disease (CVD) and led to the development of the
omega-3 index that is the proportion of eicosapentaenoic acid and docosahexaenoic acid in the erythrocyte
membranes, as a marker of CVD risk. Most methods used to measure the omega-3 index are laborious and
time consuming. Therefore, the aim of this study was to develop a high-throughput method for the extraction
and measurement of erythrocyte fatty acids and the omega-3 index. For sample extraction and quantification,
two methods were used; a single-step extraction, degradation, and derivatization method by Lepage and Roy,
followed by gas chromatography flame ionization detection (GC-FID), which is commonly used and a highthroughput method using an automated methyl tert-butyl ether extraction followed by electrospray ionization
mass spectrometry. Both methods were first applied to the analysis of known concentrations of synthetic
phospholipid (PL) mixtures to determine recovery and precision prior to their application in the analysis of
human erythrocytes. The range of recoveries over five synthetic PL mixtures were 86.4–108.9% and the
coefficient of variation was
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Abstract
Omega-3 long chain polyunsaturated fatty acids (n-3 LCPUFA) have several health benefits.
In particular, low n-3 LCPUFA status is associated with cardiovascular disease (CVD) and
led to the development of the omega-3 index which is the proportion of eicosapentaenoic
acid and docosahexaenoic acid in the erythrocyte membranes, as a marker of CVD risk.
Most methods used to measure the omega-3 index are laborious and time consuming.
Therefore, the aim of this study was to develop a high-throughput method for the extraction
and measurement of erythrocyte fatty acids and the omega-3 index. For sample extraction
and quantification two methods were used; a single-step extraction, degradation and
derivatisation method by Lepage and Roy, followed by gas chromatography flame ionization
(GC-FID) which is commonly used and a high throughput method using an automated
methyl tert-butyl ether extraction followed by electrospray ionization mass spectrometry.
Both methods were first applied to the analysis of known concentrations of synthetic
phospholipid mixtures to determine recovery and precision prior to their application in the
analysis of human erythrocytes. The range of recoveries over five synthetic PL mixtures
were 86.4% - 108.9% and the coefficient of variation was < 10% (within-run) and ≤ 15.2 %
(between-run). Both methods showed high correlation (R=0.993) for the omega-3 index and
there was no systematic bias in the detection of omega-3 index using either method. The
new high throughput method described here offers considerable advantages in terms of
simplicity and throughput compared to GC-FID method and provides additional information
on molecular phospholipid concentrations.
Abbreviations CerPCho Sphingomyelin, PtdSer Phosphatidylserine, PtdEtn
Phosphatidylethanolamine, PtdCho Phosphatidylcholine
Key words: Mass spectrometry, Omega-3 index, Gas chromatography, Docosahexaenoic
acid, Eicosapentaenoic acid.
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Introduction
Omega-3 long chain polyunsaturated fatty acids (n-3 LCPUFA), particularly
eicosapentaenoic acid (20:5n-3, EPA) and docosahexaenoic acid (22:6n-3, DHA), provide
several health benefits including enhanced cognitive function, prevention and treatment of
CVD, arthritis and other inflammatory and autoimmune disorders (Salem, 1989;
Simopoulos,1999; Bakker et al., 2003; Hibbeln et al., 2007; Marchioli et al., 2002).
Conversely, insufficient n-3 LCPUFA intake (Meyer, 2016) has been implicated in increased
risk of CVD (Mozaffarian, 2008), suboptimal neural development (Salem, Kim, & Yergy,
1986), psychiatric disorders (Hibbeln & Salem, 1995) and neurodegenerative diseases
(Calon et al., 2005).
The ‘omega-3 index’ is defined as the sum of EPA and DHA levels in erythrocyte
membranes expressed as percent of total fatty acids (Harris & Von Schacky, 2004; Harris,
2008; Von Schacky & Harris, 2007; Block et al., 2008). The omega-3 Index in the western
countries, the Middle East, Africa and Southeast Asia is believed to be ≤ 4%. In countries
where fish consumption is high such as Korea, Japan and Scandinavia the average omega3 Index is ≥ 8% and coronary artery disease is less common (Stark et al., 2016). Most
notably, it has been observed that an omega-3 index of 5% or more was associated with a
70% reduction in the risk of primary cardiac arrest (Siscovick et al., 1995). Also, similar
results suggest that whole blood EPA and DHA concentration is strongly associated with a
reduced risk of sudden death among men without evidence of prior cardiovascular disease
(Albert et al., 2002). Based on this foundation, the omega-3 index was proposed in 2004 as
a marker of risk of death from CVD (Harris & Von Schacky, 2004; Harris, 2008) and the
omega-3 index has now been widely measured in different studies that examined not only
CVD but also schizophrenia and depression (Parletta et al., 2016) .
Erythrocytes have advantages over plasma since the former reflects the last few months of
food intake (Sullivan, Williams, & Meyer, 2006; Katan et al., 1997), while plasma EPA and
DHA status is representative of food intake over the previous few days (Arab, 2003).
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Therefore, erythrocyte fatty acids are a more reliable biomarker of long-term EPA and DHA
status (Arab, 2003; Harris & Thomas, 2010). Specialized methods for extraction of lipids
from erythrocyte membranes have been developed in the past (Reed, Swisher, Marinetti, &
Enen, 1960; Rose & Oklander, 1965) and these two methods have noted the difficulty of
extracting lipids from erythrocytes. A common method used for measuring erythrocyte
membranes fatty acid concentrations including EPA and DHA (Ridges et al., 2001;
Rodriguez-Palmero et al., 1998; Stewart et al., 2007; Goozee et al., 2017) is the gas
chromatography-based method of Lepage & Roy (1986). The development of efficient
analytical techniques, to improve recovery of all lipid species, to reduce the time and amount
of labour that is involved in the estimation of fatty acids would improve the utility of
measuring the omega-3 index. Accordingly, several recent studies have improved the
throughput of gas chromatography-based fatty acid analysis (Masood, Salem, & Stark, 2005;
Masood & Salem 2008; Glaser et al., 2010)
The aims of this study were 1) to develop high throughput method for measuring erythrocyte
fatty acids and omega-3 index utilizing an electrospray ionization mass spectrometry (ESIMS)-based method and 2) to compare this new method to the commonly used Lepage and
Roy method (GC-FID method) in terms of time, sample volume and overall cost.
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Materials and Methods
Chloroform, methanol and methyl tert-butyl ether (MTBE), were purchased from VWR
International (QLD, Australia) and were high performance liquid chromatography grade or
higher. Analytical grade ammonium acetate was obtained from Crown Scientific (New South
Wales, Australia). Ethylenediaminetetraacetic acid (EDTA), butylated hydroxytoluene (BHT),
acetyl chloride, toluene and potassium carbonate (K2CO3) were all purchased from Sigma
Aldrich (NSW, Australia). Synthetic phospholipids (PL): 1-palmitoyl-2-oleoyl-sn-glycero-3phosphocholine (PtdCho 16:0/18:1), 1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine
(PtdCho 16:0/18:2), 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine (PtdCho
16:0/20:4), 1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine (PtdCho
16:0/22:6), 1-stearoyl-2-arachidonoyl-sn-glycero-3-phosphoethanolamine (PtdEtn 18:0/20:4),
1-stearoyl-2- docosahexaenoyl –sn-glycero-3-phosphoethanolamine (PtdEtn 18:0/22:6), 1palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (PtdEtn 16:0/18:1) were purchased
from Avanti Polar Lipids through Auspep (Victoria, Australia).
Disposable tips used on the Hamilton-star liquid handling workstation were purchased from
Hamilton Robotics (Reno NV, USA). 50 uL and 300 uL sizes of conductive CO-RE tips
(without filter) were used. Twin-tec PCR (Polycarbonate) clean plates and 96-well plates
were purchased from Eppendorf (POCD scientific, Australia).
Preparation Synthetic PL mixtures
The seven synthetic PL listed above were mixed in concentrations designed to mimic human
erythrocyte membranes lipid levels (additional information is available in supplementary
materials). The concentrations of PtdCho (16:0/22:6) and PtdEtn (18:0/22:6) were varied in
order to create five synthetic PL mixtures with a range of omega-3 indexes (2, 4, 6, 8 and 10
%). The synthetic PL stock solutions were stored at -80oC in 10 mL glass vials containing 2:1
methanol: chloroform with 0.01 % BHT as an antioxidant. To the best of the authors’
knowledge, there are currently no commercially available synthetic PL species containing
EPA and hence EPA was not used in these synthetic PL mixtures. Nevertheless, EPA is
present at < 1% of total erythrocyte fatty acids. In comparison, DHA is usually present at ≥ 4
5

% (Jackson et al., 1997) and therefore in the synthetic PL mixtures DHA was used to
represent the n-3 fatty acids in the omega-3 index. Synthetic PL mixtures were first analysed
in order to a determine recovery and accuracy of both methods. Analysing erythrocytes with
unknown fatty acid concentrations does not allow these parameters to be determined
accurately.
Human Erythrocytes
This study was approved by the human research ethics committee at the University of
Wollongong (HE16/016) and written consent was obtained from all participants. Participants
were recruited from the University of Wollongong staff and students. Blood samples were
collected into vacutainers coated with EDTA to prevent clotting and platelet clumping. This
followed by centrifugation at 3000 rpm at 4 oC for 10 minutes and the remaining plasma and
white blood cells removed. Aliquots 1.5 ml of erythrocytes were stored at -80 oC until
required for analysis.
Lipid extraction & direct transesterification
The method for fatty acid extraction has been described previously (Ridges et al., 2001).
Briefly, frozen (-80°C) packed erythrocytes (n=25) were thawed and 400 uL resuspended at
room temperature in a Tris buffer, which contained 10 mM Trizma Base and 2 mM EDTA
Na2 (pH 7.2) in polycarbonate ultracentrifuge tubes (16 × 76mm). The samples were
capped, gently mixed and left at room temperature for 30 minutes to induce erythrolysis.
Erythrocyte membranes were pelleted by ultracentrifugation at 49000 rpm at 4°C for 30
minutes using a 70.1 TI rotor in a Beckman L-8 ultracentrifuge (Beckman, USA). The
supernatant was discarded and removed, and the pelleted erythrocyte membranes were
resuspended in 200 µL of distilled water. Aliquots (150 µL) of resuspended erythrocytes or
synthetic PL mixtures were subjected to direct transesterification according to the method of
Lepage and Roy (1986). Briefly, 2.2 mL of a stock solution methanol: toluene (4:1) and
0.01% BHT with the internal standard heneicosaenoic acid 0.2 mg/ml) was added to the 150
µL aliquots of erythrocyte membranes resuspension or synthetic PL mixtures. Following this,
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200 uL of acetyl chloride was added while vortexing at low speed. The tubes containing this
solution were tightly sealed and heated on a heating block at 100oC for a period of 60
minutes. The tubes were cooled to room temperature in a water bath for 15 min and 6%
K2CO3 was added prior to centrifugation for 10 min at 3000 rpm at 4 oC. The extracted upper
toluene phase containing fatty acid methyl esters (FAME) was then transferred into glass GC
vials for analysis by GC-FID.
Gas chromatography-flame ionization detection (GC-FID)
The gas chromatograph (GC-2010 plus, Shimadzu, Rydalmere, NSW, Australia) was fitted
with a fused silica capillary column with 50 m x 0.25 mm internal diameter x 0.25 um film
thickness from Agilent J & W GC Columns with the following temperature program: 150oC
initial temperature, 10oC/min to 162.5oC, 0.4oC/min to 172.5oC and 10oC/min to 211oC, the
injector and detector temperature were set at 250oC. The carrier gas was ultra-high purity
hydrogen and the column flow rate was 2.0 mL/min. Column pressure was maintained at
157.1 kPa. The split ratio was set at 20:1. One microliter of each sample was injected onto
the column using an auto injecting unit (Shimadzu AOC-20i) and the fatty acids were
detected using FID. The total analysis time was approximately 30 minutes per sample with
fatty acids eluting between 2.5 and 25 minutes. The fatty acids were identified by comparing
their retention time with known fatty acid standards (Nu-chek and Sigma, Sydney, NSW,
Australia). After analysis, each fatty acid was quantified by comparing their peak area to the
peak area of internal standard.
Adaptation of a lipid extraction protocol to a robotic platform
To assess the suitability of existing protocols to a robotic platform several key properties
were evaluated. They were: 1) the ability of the homogeising solvent to lyse erythrocytes, 2)
the impact of the solvent on erythrocyte clotting, 3) the ability to convert the protocol to small
volumes (<2000 µL) to fit a 96-well plate configuration, 4) an organic phase with a lower
desity than water to allow removal of lipids from the top layer of the two-phase system, and
5) spontaneous phase separation (removing the need to centrifuge samples). The protocol
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described by Matyash et al., (2008) appeared to fulfil many of these criteria and was chosen
as the method used in the current investigation.
The MTBE extraction protocol was initially tested manually using packed erythrocytes. The
first observation made was the difficulty of pipetting packed erythrocytes from the eppendorf
tubes in which they were stored. The second notable observation was the tendency of
erythrocytes to form an insoluble mass upon the addition of combined MTBE and methanol.
This was quite different from what occurs with the Lepage & Roy (1986) method where the
addition of Tris buffer to the packed erythrocyte causes the cellular membranes to
immediately lyse with no sedimentation of the celluar membranes upon standing. The
clumping suggested that the membrane bound proteins had become denatured in the
presence of the organic solvents used. Furthermore, it was also unclear if the erythrocyte
membranes had been effectively lysed by the addition of solvents. This was an important
consideration as without the membrane being properly lysed, the lipids contained within the
membrane bi-layer would not be exposed to the solvents and it would not be possible to
solubilise the lipids in the following steps thus making the protocol ineffective for its proposed
means. The focus of refining the MTBE protocol thus turned to how the erythrocyte
membranes could be effectively lysed as well as preventing the “clotting”.
After testing several solvent sytems (see supplementary material), we decided to use a 150
mM ammonium acetate solution due to its ability to lyse erythrocytes, prevent clotting and is
compatible with MS analysis. The Matyash et al., (2008) method reports the use of large
volumes of both the sample to be analysed and the reagents used in the protocol (matyash
et al., 2008). The starting volume of plasma used was 200 uL to which 1.5 mL of methanol is
added. Upon the addition of 5mL of MTBE this far exceeds the 2mL of the standard format
96-well plates. Hence, the first amendment made to the protocol was to reduce the volumes
used. To begin with, 10 uL was arbitrarily assigned as the volume of packed erythrocytes on
which the extraction would be performed. It was then calculated that the ratio of specimen to
methanol used by matyash et al., (2008) was 1:7 (sample: methanol v/v) and that the solvent
system used comprised of MTBE: methanol: aqueous reagents in the ratio 10:3:2.9 (v/v/v).
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Applying these ratios to the new starting amount of 10 uL packed erythrocytes created a
protocol where the highest volume reached was 1600 µL. This is in line with the proposed
requirement for robot extraction that the highest volume reached is ≤2000 µL. This protocol
was then applied to the automated extraction as decribed below.
Automated Lipid Extraction
For ESI-MS analysis, lipids where extracted from erythrocytes (n=25) and synthetic PL
mixtures (n=5) using the method of Matyash et al., (2008), with some modifications. In the
automated extraction method, 290 uL of an aqueous mixture containing 150 mM Ammonium
acetate and 2 mM EDTA was added to the wells of a 2.0 mL 96-well plate on ice. Aliquots of
10 µL taken from the synthetic PL mixtures or erythrocytes were then added to the wells
prior to vortexing at 800 rpm for 10 minutes. Robotic procedures were then started with all
plates, solvents and reagents loaded onto the automated liquid handling workstation
(Hamilton, Nevada, USA). A 300 µL aliquot of an internal standard mixture in methanol [500
uM (PtdCho 19:0_19:0); 166.7 uM (PtdEtn 17:0_17:0); 100 uM (PtdSer 17:0_17:0); 500 uM
(CerPCho 18:0_12:0)] was added to the wells prior to mixing and standing for 10 minutes.
Then 1 mL of MTBE was added to the wells and mixed for 30 minutes before the mixture
was allowed to stand for 15 minutes to allow phase separation. Following this, 500 µL of the
MTBE top phase was removed to the extraction plate (containing the extracted PL) and 40
µL of this extract was transferred to another 96-well plate and diluted with 760 µL of a 2:1
(v:v) methanol: chloroform solution containing 5 mM Ammonium acetate. A 40 µL aliquot of
the diluted extract was transferred to another 96-well plate, which was sealed with aluminum
foil prior to analysis by mass spectrometry.
Electrospray ionization mass spectrometry (ESI-MS)
Mass spectrometry was performed utilizing a hybrid triple quadrupole linear ion trap mass
spectrometer (QTRAP 5500 ,Sciex, MA, USA) with an automated chip-based
nanoelectrospray source (Triversa NanoMate, Advion Biosciences, New York, USA) as
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previously described (Brown et al., 2013; Norris et al., 2015). A 10 uL aliquot of lipid extract
diluted in methanol: chloroform (2:1 v/v) containing 5mM ammonium acetate (approximately
10 uM) was infused into the nano-electrospray ion source. Spray parameters were a voltage
of 1.1 kV for negative ion acquisition and 1.2 kV for positive ion acquisition and a nitrogen
gas pressure of 0.40 psi (Brown et al., 2013; Norris et al., 2015). Lipids were identified using
precursor ion and neutral loss scans as show in Supplementary Table S7. Specifically,
precursor ion scans for phosphocholine cations (m/z 184.1) were used to detect PtdCho and
CerPCho species while neutral loss scans were used to detect PtdEtn species
(phosphoethanolamine loss, 141.0 Da) and PtdSer species (phosphoserine loss, 185.0 Da)
(Brugger et al. 1997). The identitiy of the FA component of each PL was determined using
precursor ion scanning for each FA in negative ion mode (Supplementary Table S7).
Ionized lipids identified with a minimum signal-to-noise ratio of 10 were included in the
analysis. Identification and quantification was accomplished using LipidView software
(version 1.2, Sciex, MA, USA) this included smoothing, identification, removal of isotope
contribution from lower mass species, and correction for isotope distribution, as described
(Brown et al., 2013; Norris et al., 2015). Quantification was performed using LipidView
software by comparing the spectral peak area of individual lipids to their class specific
internal standards following isotope correction. Fatty acid concentrations were then
determined directly from PL concentration i.e. the concentration of each fatty acid is
equivalent to the parent. For example if PtdCho 16:0_18:0 is 1.5 nmol/ml then the fatty acid
16:0 and fatty acid 18:0 are both 1.5 nmol/ml. Isobaric phospholipids e.g. PtdCho 16:0/22:6
and PtdCho 18:1/20:5 were resolved using fatty acid precursor ion scans. The concentration
obtained from the head group scan was multiplied by the ratio of the relative abundance of
each fatty acid pair to obtain the concentration of each molecular PL as described previously
(Nealon, Blanksby, Mitchell, & Else, 2008). An excerpt (plus explanatory comments) from the
spreadsheet where these calculations were performed is show in Supplementary Figure S1.
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A quality control (QC) sample was produced using pooled erythrocytes from healthy
volunteers (n = 10, 5 male and 5 female) aged between 13 and 40 years. The QC aliquots
were stored frozen at (−80 °C). With each full plate prepared (96 well plate) in the highthroughput ESI-MS method 3 QC samples distributed in positions (2, 49 and 95) to monitor
instrument performance and assay precision. To assess contamination and interference 3
blank samples were processed side-by-side with analytical samples and placed in positions
(1, 48 and 96) of each 96-well plate. Additionally, blanks were used to correct the data by
subtracting blank readings from sample readings.

Statistics
Statistical analyses were performed using Microsoft excel and SPSS statistics. Pearson’s
correlation coefficient (r) was determined and tested for significance via two-tailed analysis.
A Bland-Altman plot was produced to assess the agreement between the two methods
(Bland & Altman, 1986; Altman & Bland, 2002; Ludbrook, 2010).
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Results and Discussion
Recovery
Extraction recovery was tested to evaluate the accuracy of the method. As is evident in table
1 recovery and detection in both the GC-FID and the high-throughput ESI-MS methods was
greater than 86% for most fatty acids.
An unexpected result was the low recovery of 18:0 using the MS-based method (50.961.3%) and 22:6 using both methods (66.9-85.1% for GC-FID method and 63.5-75.3% for
ESI-MS method). Interestingly, PtdEtn (18:0/22:6), was noticeably yellow in colour inside the
2.5 mL ampule (starting material), suggesting oxidation had occurred and may explain these
findings. The GC-FID method measures only the fatty acids and not the whole PL molecule.
This means that only the data for the oxidized fatty acid is altered; i.e. a lower than expected
22:6 level was detected. This is in contrast to the high-throughput ESI-MS method, which
measures the intact PL. Therefore, when one fatty acid is oxidized the data from both fatty
acids in that particulalr PL species is lost. In the case of oxidized PtdEtn (18:0/22:6) both
22:6 and 18:0 would be reduced as observed. If the concentration of PtdEtn (18:0/22:6) add
to the synthetic mixtures is removed from the expected values, the recovery of 18:0 of using
the ESI-MS method increases to (70.3-99.3%) and 22:6 is improved for both methods (83.7106.4% for the GC-FID method and 81.2-94.1% for the ESI-MS method).
Precision
Precision was assessed by estimating within-run and between-run %CV for both methods as
shown in Table 2.
The within-run %CV of each fatty acid in each synthetic PL mixture for both the GC-FID
method and the high-throughput ESI-MS methods were calculated for n=3 (Table 2). The
within-run precision for high-throughput ESI-MS method was less than 10% and this is
comparable to the GC-FID method. The high-throughput ESI-MS method also shows
comparable results for within-run precision with previously published work using gas
12

chromatography-flame ionization detection (GC-FID) fatty acid analysis (CV < 8% and <
14%) (Glaser et al., 2010; Lin et al., 2012) and gas chromatography/mass spectrometry
analysis GC-MS (CV <14%) (Quehenberger, Armando, & Dennis, 2011).
Measurement of between-run precision was calculated for samples of synthetic PL mixtures
(n=3/day) over one month (Table 2). The between-run %CV in high-throughput ESI-MS
method was slightly higher (≤15.2%) compared to the between-run coefficient of variation
(≤13.9%) observed in the GC-FID method. Nevertheless, the between-run coefficient of
variation observed in the high-throughput ESI-MS method was comparable to that of
previous GC-FID and GC-MS fatty acid analyses (CV <16% and <17%) (Lin et al., 2012;
Quehenberger, Armando, & Dennis, 2011). The QC samples intra-assay (within batch)
precision ranged from 0.90% to 17.4% of 19 batches and the average inter-assay (batch-tobatch) precision ranged from 6.9% to 20% of 19 batches. (See supplementary material table
S9 for QC sample fatty acid concentration)
Measurement of erythrocyte fatty acids and omega-3 index using two methods
There is a strong correlation (R= 0.993) between the GC-FID method and the high
throughput ESI-MS method when assessing omega-3 index over a range of 2-10% (figure
1).
There was good agreement between the two methods across the range of omega-3 index
(2-10%) with all points plotted falling within both the upper and lower limits of agreement
(95% CI) as shown in figure 2. There was no systematic bias in the detection of omega-3
index extracted using either method. To the best of the authors’ knowledge, this is the first
validation study using Bland-Altman plot in comparing the difference between the two
methods measuring fatty acids. The reporting of correlation coefficients can be misleading
as correlations measure the strength of a relationship between two methods rather than the
level of agreement between the results yielded by two methods (Bland & Altman, 1986). As
described by Bland and Altman (1986) a significant correlation is expected if two measures
13

are measuring same thing. As such, studies validating a novel method against a reference
method should be interpreted with caution where validity is measured and reported by way
of correlation.
The concentration of erythrocytes fatty acids as determined by the GC-FID method and the
high throughput ESI-MS method are presented in Table 3. The difference between the two
methods was less than 10% with exception for fatty acid 22:4, where the difference was
37.5%. The abundance of fatty acid 22:4 is relatively low. The amount of 22:4 measured by
the GC-FID method detects the total fatty acid amount obtained from all PL species in a
single GC peak. This is advantageous as it improves signal -to-noise and therefore
sensitivity of fatty acid with low relative abundance. Because 22:4 is of relatively low total
abundance and was bound to several different PL species, the signal obtained by ESI-MS
was further diluted. This results in a decreased signal-to-noise and therefore, some 22:4
containing PLs were below the limit of quantification and are not included in the MS totals
(but would be included in the GC analysis).
Sample derivatization is required to improve fatty acid volatility (Brondz, 2002). Nowadays,
procedures allowing simultaneous hydrolysis and methylation of bound fatty acids are
becoming more and more popular. Lepage & Roy (1986) have proposed the one-step direct
transesterification procedure suitable for fatty acid classes. The analysis of fatty acid methyl
esters (FAME) from erythrocyte membranes may be differentially affected by the method of
lipid extraction. Rodrıg
́ uez-Palmero coworkers compared direct (Lepage & Roy) and
conventional esterification (Folch) methods and found that the direct method has substantial
advantages over the conventional method in terms of reduce contamination and increased
throughput. However, the transesterification of amides from sphingomyelin (CerPCho) is less
efficient than that of esters from glycerophospholipids (Christie & Han, 2012); this results in
an underestimation of fatty acids bound to CerPCho when using the GC-FID method
described here.
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To determine the transesterification efficiency of sphingomyelin using the Lepage and Roy
method CerPCho 24:1 was added to the synthetic PL mixture shown in table S5. This
mixture was then subjected to both the GC and MS methods described earlier and the
results shown in the supplementary material (Table S6). A very low recovery (45%) was
obtained using the GC-FID method compared to 98% recovery using the high-throughput
ESI-MS method. In order to account for this underestimation a correction factor was
determined and applied as follows. Five erythrocytes samples were selected at random and
the concentration of fatty acid 24:1 obtained from the high-throughput ESI-MS method (123
nmol/ml blood) was divided by the fatty acid 24:1 concentration determined by the GC-FID
method (49.5 nmol/ml blood). This produced a correction factor of 2.48. Fatty acid 24:1 was
chosen to calculate the correction factor as it was found exclusively bound to CerPCho in
erythrocytes. To correct for fatty acids exclusive to CerPCho, i.e. 24:1 and 24:0 the GC-FID
data was simply multiplied by 2.48 (the correction factor).
For fatty acids bound to both phospholipids and CerPCho (16:0, 18:0 and 18:1) further
calculations were required to determine the corrected fatty acid concentrations. They were;
1) dividing the concentration of CerPCho bound fatty acid by the total fatty acid
concentration (both determined by ESI-MS) for 16:0, 18:0 and 18:1 in every sample to obtain
the proportion of CerPCho fatty acid, 2) multiplying the GC data by this proportion to obtain
the approximate CerPCho fatty acid concentration, 3) multiplying the calculated CerPCho
fatty acid concentration by the correction factor (2.48), and 4) adding the corrected CerPCho
fatty acid concentration to the PL fatty acid concentration. A step-by step example of this
calculation is provided in the supplementary material. The result of applying the correction
factor to 16:0, 18:0, 18:1, 24:0 and 24:1 concentrations determined by GC-FID are shown in
Table 3.
As shown in the table 4 the new method is cheaper than the GC-FID method with several
other advantages e.g. throughput is increased by almost 8 times; sample and reagent
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volumes can be reduced four-fold and additional information, i.e. phospholipid class and
species information is obtained.
The throughput ESI-MS method does however, have limitations. First the diluting of signal
from low relative abundance fatty acids across several PL species can hinder their detection.
Second, the double bond location cannot be determined, e.g., this method is unable to
determine whether 22:5 docosapentaenoic acid is 22:5n-3 or 22:5n-6 or if 18:1 is 18:1n-9 or
18:1n-7. While several MS-based methods for determining double bond position have been
developed they are not yet amenable to high-throughput, quantitative anlysis (Hancock et al.
2017). Nevertheless, future addition of such techniques will further enhance the analysis of
FAs and the omega-3 index. Additionally, pipetting of 10 uL of packed erythrocytes
introduced variation between samples (data not shown), as pipetting this volume of packed
cells is difficult. Given that sample volume is generally not limited in this process, the initial
starting volume of erythrocytes could easily be increased to further reduce variability
between sample measurements. This could possibly be achieved using the robotic system to
initially pipette a larger cell volume and perform hemolysis prior to aliquoting a small volume
of the lyzed cell mixture for extraction.
In conclusion, the high throughput ESI-MS method described here allows the determination
of human erythrocyte fatty acid concentration and omega-3 index from low sample volumes.
The method is convenient, simple, low in cost and significantly increases throughput
compared to the reference GC-FID method. Consequently, the method is well suited for
application in epidemiological studies and large clinical trials.
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Figure legends
Figure 1:- Correlation between the GC-FID method and the high throughput ESI-MS method
using erythrocyte samples (n=25) over an omega-3 index range of 2-10%. The line of best fit
is y = 1.01567x. R= 0.993.
Figure 2:- Bland-Altman plot of the difference between the two methods (the high
throughput ESI-MS method minus GC-FID method) against their mean of omega-3 index
(%) using erythrocytes (n=25). The line of best fit (dashed line) is y = 02 + -0.01x (R² =
0.015). {95 % confidence interval = Mean difference ± (STD of difference * 1.96)} STD =
0.235.
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Table 1:- Average amount of synthetic PL mixtures (nmol/ml) across a range of omega-3 indexes recovered using the GC-FID and highthroughput ESI-MS methods (n=3 for all mixtures).
* Synthetic PL
mixtures (%)

Fatty acids

Expected value

2

16:0
18:0
18:1
18:2
20:4
22:6

nmol/ml
941.5
58.5
444.6
363.8
151.6
40.0

Mean ± SEM
930.0 ± 24.3
57.8 ± 0.9
429.8 ± 15.9
344.9 ± 2.7
147.4 ± 7.5
27.8 ± 0.2

(%) recovery of synthetic PL
98.8%
98.8%
96.7%
94.8%
97.2%
69.6%

Mean ± SEM
929.9 ± 10.1
35.5 ± 0.2
406.5 ± 11.5
396.0 ± 2.6
132.8 ± 5.5
30.1 ± 0.9

4

16:0
18:0
18:1
18:2
20:4
22:6

935.6
64.4
426.1
348.6
145.3
80.0

927.0 ± 17.8
64.9 ± 1.9
423.1 ± 3.3
347.8 ± 10.8
141.9 ± 4.4
56.5 ± 1.9

99.1%
100.8%
99.3%
99.8%
97.7%
70.6%

890.1 ± 13.9
36.9 ± 2.0
400.3± 7.83
341.3 ± 3.1
125.5 ± 1.9
59.9 ± 1.7

95.1%
57.3%
93.9%
97.9%
86.4%
74.8%

6

16:0
18:0
18:1
18:2
20:4
22:6

929.7
70.3
407.6
333.5
138.9
120.0

827.0 ± 7.8
67.9 ± 1.7
386.7 ± 3.2
316.7 ± 2.2
128 ± 1.6
80.3 ± 1.2

88.9%
96.6%
94.9%
94.9%
92.4%
66.9%

893.4 ± 3.0
40 ± 0.9
401.2 ± 4.5
329.1 ± 6.2
125.4 ± 2.8
77.9 ± 0.9

96.1%
57.2%
98.4%
98.7%
90.3%
64.9%

16:0
18:0
18:1
18:2
20:4
22:6

923.8
76.2
389.1
318.3
132.6
160.0

907.4 ± 19.1
75.8 ± 3.1
384.2 ± 9.9
313.7 ± 1.6
121.0 ± 6.1
136.2 ± 9.3

98.2%
99.4%
98.7%
98.6%
91.6%
85.1%

855.3 ± 4.7
41.9 ± 0.4
374.2 ± 6.4
301.2 ± 1.7
120.1± 0.8
101.7±1.9

92.6%
54.9%
96.2%
94.6%
90.6%
63.5%

8

GC-FID method

The high-throughput ESI-MS method

879.3 ± 8.6
41.8 ± 1.6
360.2 ± 5.3
294.0 ± 4.6
118.5 ± 0.5
148.4 ± 5.2
SEM, standard error of the mean. * See supplementary materials (Tables S1 to S5) for additional Synthetic PL mixtures information.
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16:0
18:0
18:1
18:2
20:4
22:6

917.9
82.1
370.5
303.2
126.6
200.0

896.3 ± 3.6
83.9 ± 0.4
367.9 ± 2.6
303.6 ± 1.4
125.6 ± 8.5
149.1 ± 1.7

97.6%
102.3%
99.3%
100.1%
99.2%
74.5%

(%) recovery of synthetic PL
98.8%
60.7%
91.4%
108.9%
87.6%
75.3%

95.8%
50.9%
97.2%
96.9%
93.6%
74.2%

Table 2: Within–run and between-run precision for the GC-FID and high-throughput ESI-MS methods.
*Synthetic
PL mixtures
(%)
2

Fatty
acids

4

16:0
18:0
18:1
18:2
20:4
22:6

927.0 ± 17.8 (3.3)
64.9 ± 1.9 (4.9)
423.1 ± 3.3 (1.3)
347.8 ± 10.8 (5.3)
141.9 ± 4.4 (5.3)
56.5 ± 1.9 (5.7)

924.8 ± 18.0 (6.2)
65.8 ± 2.5 (12.0)
420.7 ± 4.0 (3.0)
352.1 ± 10.0 (8.9)
136.7 ± 5.0 (11.6)
55.0 ± 1.5 (8.6)

890.1 ± 13.9 (2.7)
36.9 ± 2.0 (9.2)
400.3± 7.8 (3.3)
341.3 ± 3.1 (1.5)
125.5 ± 1.9 (2.6)
59.9 ± 1.7 (4.8)

843.4 ± 19.8 (7.5)
35.9 ± 1.3 (11.4)
379.8 ± 11.1 (9.2)
327.9 ± 10.4 (10.0)
113.4 ± 3.1 (8.6)
57.3 ± 1.4 (7.7)

6

16:0
18:0
18:1
18:2
20:4
22:6

827.0 ± 7.8 (1.6)
67.9 ± 1.7 (4.3)
386.7 ±3.2 (1.4)
316.7 ± 2.2 (2.6)
128 ± 1.6 (2.1)
80.3 ± 1.2 (2.5)

835.2 ± 8.9 (3.4)
70.9 ± 2.8 (12.5)
397.5 ± 4.1 (3.3)
325.1 ± 3.7 (3.6)
130.1 ± 1.9 (4.6)
81.2 ± 3.1 (12.1)

893.4 ± 3.0 (0.6)
40.0 ± 0.9 (3.8)
401.2 ± 4.5 (1.9)
329.1 ± 6.2 (3.2)
125.4 ± 2.8 (3.8)
77.9 ± 0.9 (1.9)

905.5 ± 5.5 (1.9)
41.7 ± 2.0 (15.2)
395.1 ± 8.4 (6.7)
309.7 ± 9.5 (9.7)
119.0 ± 5.5 (14.6)
75.2 ± 1.1 (4.6)

16:0
18:0
18:1
18:2
20:4
22:6

907.4 ±19.1 (3.6)
75.8 ± 3.1 (6.9)
384.2 ± 9.9 (4.4)
313.7 ± 1.6 (0.9)
121.0 ± 6.1 (8.6)
136.2 ± 8.0 (10.0)

929.4 ± 20.2 (6.9)
76.9 ± 3.4 (13.9)
379.6 ± 10.5 (8.7)
323.2 ± 1.9 (1.9)
118.3 ± 5.0 (13.4)
132.2 ± 5.8 (13.9)

855.3 ± 4.7 (0.2)
41.9 ± 0.4 (1.6)
374.2 ± 6.4 (2.9)
301.2 ± 1.7 (0.9)
120.1± 0.8 (1.1)
101.7±1.9 (3.2)

778.9 ± 20.9 (8.5)
40.5 ± 1.9 (14.8)
334.5 ± 11.2 (10.6)
283.6 ± 6.6 (7.4)
105.8 ± 4.6 (13.7)
95.6 ± 2.5 (8.3)

16:0
18:0
18:1
18:2
20:4
22:6

896.3 ± 3.6 (0.7)
83.9 ± 0.4 (0.6)
367.9 ± 2.6 (1.2)
303.6 ± 1.4 (0.6)
125.6 ± 6.5 (8.8)
149.1 ± 1.7 (1.9)

900.9 ± 4.5 (1.6)
84.8 ± 1.2 (4.5)
364.9 ± 2.9 (2.5)
307.9 ± 1.5 (1.5)
118.2 ± 5.1 (13.6)
144.3 ± 2.4 (5.3)

879.3 ± 8.6(1.7)
41.8 ± 1.6 (6.5)
360.2 ± 5.3 (2.5)
294.0 ± 4.6 (2.7)
118.5 ± 0.5 (0.7)
148.4 ± 5.2 (5.9)

813.4 ± 21.5 (8.4)
42.6 ± 1.9 (14.0)
341.7 ± 14.9 (13.8)
261.7 ± 10.2 (12.3)
106.4 ± 4.1 (12.2)
146.2 ± 4.9 (10.6)

8

10

16:0
18:0
18:1
18:2
20:4
22:6

GC-FID method
Mean nmol/ml ± SEM (within-run
Mean nmol/ml ± SEM (between-run
%CV)
%CV)
962.1 ± 36.4 (11.9)
930.0 ± 24.3 (4.4)
59.4 ± 1.5 (7.9)
57.8 ± 0.9 (2.6)
429.8 ± 15.9 (6.3)
443.3 ± 16.5 (11.8)
344.9 ± 2.7 (1.3)
362.9 ± 3.0 (2.6)
147.4 ± 7.5 (8.7)
145.0 ± 5.5 (11.9)
27.6 ± 1.0 (11.4)
27.8 ± 0.2 (1.2)

The high-throughput ESI-MS method
Mean nmol/ml ± SEM (within-run
Mean nmol/ml ± SEM (between-run
%CV)
%CV)
929.9 ± 10.1 (1.8)
831.6 ± 22.2 (8.4)
35.5 ± 0.2 (0.9)
36.5 ± 0.4 (3.5)
406.5 ± 11.5 (4.8)
375.8 ± 8.9 (7.5)
335.8 ± 14.2 (13.4)
396.0 ± 2.6 (1.1)
127.4 ± 3.4 (8.4)
132.8 ± 5.5 (7.0)
30.1 ± 0.9 (5.1)
29.1 ± 0.5 (5.4)

Coefficient of variation (%CV). SEM, standard error of the mean. Within run %CV (n=3); between run %CV (n= 3/day over one month).* See supplementary materials
(Tables S1 to S5) for additional Synthetic PL mixtures information.
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Table 3: comparison of erythrocytes fatty acids concentrations using GC-FID method and
high throughput ESI-MS method. (nmol/ml blood) (n=25)
Fatty
acids

GC-FID method
(Mean ± SEM)

GC-FID method (Mean ±
SEM) corrected

16:0
17:0
18:0
24:0
16:1
18:1
24:1
18:2
20:3
20:4
20:5
22:4
22:5
22:6

331.8 ± 8.4
16.6 ± 0.8
232.9 ± 6.2
37.7 ± 2.1
4.9 ± 0.8
186.5 ± 4.4
49.5 ± 1.8
155.1 ± 6.9
23.8 ± 1.6
201.7 ± 5.2
9.8 ± 1.1
37.6 ± 1.6
31.5 ± 1.6
67.6 ± 3.3

460.3 ± 8.6
263.8 ± 5.5
93.5 ± 2.9
198.0 ± 3.3
122.7 ± 3.6
-

high throughput ESIMS method
(Mean ± SEM)
464.9 ± 7.3
18.1 ± 0.8
269.3 ± 7.1
85.0 ± 2.6
4.6 ± 0.7
207.3 ± 3.9
122.7 ± 3.6
158.1 ± 6.4
22.9 ± 1.6
195.7 ± 4.3
9.9 ± 1.2
25.7 ± 1.9
31.1 ± 1.5
66.7 ± 3.2

Difference
%
N/A*
-8.6
N/A*
N/A*
6.3
N/A*
N/A*
-1.9
3.9
3.0
-1.0
37.5
1.3
1.3

Corrected data shown in bold, Values (V), Difference % = |V 1 − V 2| / (V 1 +V 2) / 2 × 100. (V1 GC-FID results)
& V2 ESI-MS results). N/A* (the difference % was not calculated because the data has been corrected using the
new method).
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Table 4: comparison between methods using GC-FID method and high throughput ESI-MS
method.
GC-FID method

high throughput ESI-MS method

Number of samples per day

24 samples per day

186 samples per day

Time needed for sample

Approximately 6 hours

Approximately 6 hours to prepare

preparation

to prepare 24 samples

186 samples

Quantity of sample used

400 uL

10 uL

Data acquired

Only fatty acids

Fatty acids
PL classes

Quantity of solvents used
8 ml

Approximately 2 ml

$ 50

$ 20

per sample
Cost per sample
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